• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.76% Nasdaq Down1.54%

    Eli Lilly and Company (LLY)

    -NYSE
    71.67 Down 0.44(0.62%) 12:29PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
    Total Revenue 4,935,600   4,683,100   5,808,800   5,772,600  
    Cost of Revenue1,189,700  1,222,700  1,386,500  1,198,100  
    Gross Profit 3,745,900   3,460,400   4,422,300   4,574,500  
    Operating Expenses
    Research Development1,195,400  1,109,300  1,475,400  1,377,400  
    Selling General and Administrative1,719,900  1,428,900  1,944,500  1,142,600  
    Non Recurring -  31,400  92,500   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss 830,600   890,800   909,900   2,054,500  
    Income from Continuing Operations
    Total Other Income/Expenses Net109,800   -   -  (541,100)
    Earnings Before Interest And Taxes940,400  890,800  909,900  1,513,400  
    Interest Expense -   -   -   -  
    Income Before Tax940,400  890,800  909,900  1,513,400  
    Income Tax Expense206,900  162,900  182,400  310,300  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops733,500  727,900  727,500  1,203,100  
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 733,500   727,900   727,500   1,203,100  
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 733,500   727,900   727,500   1,203,100  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.